The agreement includes provisions for the rapid sharing of data about new diseases, to ensure scientists and pharmaceutical companies can work more quickly to develop treatments and vaccines

Most companies said bringing back supply chains within the U.S. could as much as double their costs, and it would be more cost-effective to relocate them to lower-tariffed countries.

For companies looking to reduce packaging spend, cost-cutting alone is no longer enough. Sustainability must also be a priority. 

Even balanced against elevated levels earlier this year, total 2025 cargo volume could show a net decline of 15% or more unless the situation with tariffs changes.

An April 8 release from the university details concerns over the quality, transparency and resiliency of global pharmaceutical supply chains.

If anything, Trump's delay in some of his tariff plans is extending the uncertainty that has already begun to drag on business and consumer sentiment.

Pharmaceuticals have so far been exempted from the levies, but on April 8, Trump said he would announce a large tariff on drugs imports “very shortly.”

The rise of digital supply chain networks represents a significant shift in how the pharma and life sciences industry approaches supply chain management.

Kirk Serjeantson, chief information officer with American Expediting, and Arthur Axelrad, CEO and co-founder of Dispatch Science, relate how the shipper consolidated multiple transportation management systems.

Karen Betancourt, chief executive officer of Vanguard Medical and a former supply chain exec at Walmart and other multinationals, talks about the challenges and personal fulfillment she experiences in bringing needed medical supplies and equipment to patients in Latin America.